TECH OUTLOOKAugust - 20185Artificial Intelligence in Pharma R&D: A Disruption of an IndustrySlava Akmaev, SVP, Chief Analytics Officer, Co-founder & Head of Berg Analytics, BERG HealthImpact of Medication-Assisted Treatment (MAT) for Opioid DependenceBrady Granier, President & CEO, Director, BioCorRx IncHitting the Reset Button on Supplier RelationshipsRonald Ortiz, Director Manufacturing Science & Technology, Pacira Pharmaceuticals, Inc.Shaping the Future of Human Wellness through Modern TechnologyManoj Vig, Head, Clinical Data Repository, IQVIAEmerging Biopharma Gains Competitive Advantage in the CloudDoug Caldwell, Vice President, Customer Architecture, Veeva SystemsPg 14 - 32IN MY OPINIONCXO INSIGHTS2925170836Dale Danilewitz, Executive Vice President and CIO, AmerisourceBergenMaintaining a Patient-Focused Community Pharmacy with Consumer TechnologyTECH OUTLOOK2018 ENTERPRISE SOFTWARE38
< Page 4 | Page 6 >